Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 Feb;139(2):699-703.e7.
doi: 10.1016/j.jaci.2016.06.063. Epub 2016 Sep 14.

Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois

Affiliations
Clinical Trial

Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois

Bruce K Tan et al. J Allergy Clin Immunol. 2017 Feb.

Abstract

CRSsNP is a heterogenous disease but type 2 inflammation in CRSsNP was more common than type 1 inflammation among patients in Chicago, Illinois. Distinct therapeutic strategies may be needed depending on the type of inflammation found in CRSsNP.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest as to the interpretation and presentation of this manuscript.

Figures

Fig. 1
Fig. 1. Messenger RNAs for markers of type 2 and 3 inflammation were elevated in CRSsNP
Total RNA was extracted from whole tissue of control IT (n=19), control UT (n=21), control ET (n=33), CRSsNP IT (n=53), CRSsNP UT (n=44), CRSsNP ET (n=61), CRSwNP IT (n=28), CRSwNP UT (n=29), CRSwNP ET (n=40) and CRSwNP NP (n=48). Expression of mRNAs for IFN-γ, CLC, IL-5, IL-13 and IL-17A was analyzed using real-time RT-PCR. Gene expression was normalized to a housekeeping gene, β-glucuronidase (GUSB), and expression levels were shown as % expression of GUSB. Results are shown as medians (25% to 75% interquartile ranges) (A, B) or mean ± SEM (C). Dotted line indicates the threshold based on the 95th percentile expression in control ET (CLC: 96.4, IL-5: 36.5, IL-13: 11.2, IFN-γ: 13.2, IL-17A: 12.1) (C). In order to display undetectable data, we plotted 0 as 0.01 in the log scaled figures (C). * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, by one-way ANOVA.
Fig. 2
Fig. 2. Type 2 and 3 cytokines were elevated in CRSsNP tissue protein extracts
Protein extracts were generated from ET of control (n=34), CRSsNP (n=83) and CRSwNP (n=45) and from NPs (n=60). Expression of ECP, IL-5, IL-13, IFN-γ and IL-17A proteins in tissue homogenates was measured using ELISA and Luminex. The protein concentrations were normalized to the concentration of total protein. Dotted line indicates the threshold based on the 95th percentile expression in control ET (ECP: 131.5 ng/mg, IL-5: 0.02 pg/mg (detectable), IL-13: 5.5 pg/mg, IFN-γ: 8.1 pg/mg, IL-17A: 0.02 pg/mg (detectable)). In order to display undetectable data, we plotted 0 as 0.01 in the log scaled figures. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, by one-way ANOVA.

References

    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;3:1–298. - PubMed
    1. Kato A. Immunopathology of chronic rhinosinusitis. Allergol Int. 2015;64:121–30. - PMC - PubMed
    1. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280–9. - PubMed
    1. Van Bruaene N, Perez-Novo CA, Basinski TM, Van Zele T, Holtappels G, De Ruyck N, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121:1435–41, 41 e1–3. - PubMed
    1. Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013;132:593–600 e12. - PMC - PubMed

Publication types

MeSH terms